EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals

Lisa Saiman, Susan E Coffin, Larry K Kociolek, Danielle M Zerr, Aaron M Milstone, Margaret L Aldrich, Celibell Y Vargas, Giovanny Zapata, Morgan A Zalot, Megan E Reyna, Amanda Adler, Annie Voskertchian und 6 weitere

Journal of the Pediatric Infectious Diseases Society · 2023

DOI: 10.1093/jpids/piad030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2023. Verfasst von Lisa Saiman und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, NewYork-Presbyterian Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: COVID-19, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Infections, Cross Infection. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck Sharp & Dohme LLC, Merck & Co., Inc, Spring SHEA, Colorado Springs, CO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Outbreaks of healthcare-associated respiratory syncytial virus (HA-RSV) infections in children are well described, but less is known about sporadic HA-RSV infections. We assessed the epidemiology and clinical outcomes associated with sporadic HA-RSV infections.

Methods

We retrospectively identified hospitalized children ≤18 years old with HA-RSV infections in six children’s hospitals in the United States during the respiratory viral seasons October–April in 2016–2017, 2017–2018, and 2018–2019 and prospectively from October 2020 through November 2021. We evaluated outcomes temporally associated with HA-RSV infections including escalation of respiratory support, transfer to the pediatric intensive care unit (PICU), and in-hospital mortality. We assessed demographic characteristics and comorbid conditions associated with escalation of respiratory support.

Results

We identified 122 children (median age 16.0 months [IQR 6, 60 months]) with HA-RSV. The median onset of HA-RSV infections was hospital day 14 (IQR 7, 34 days). Overall, 78 (63.9%) children had two or more comorbid conditions; cardiovascular, gastrointestinal, neurologic/neuromuscular, respiratory, and premature/ neonatal comorbidities were most common. Fifty-five (45.1%) children required escalation of respiratory support and 18 (14.8%) were transferred to the PICU. Five (4.1%) died during hospitalization. In the multivariable analysis, respiratory comorbidities (aOR: 3.36 [CI95 1.41, 8.01]) were associated with increased odds of escalation of respiratory support.

Conclusions

HA-RSV infections cause preventable morbidity and increase healthcare resource utilization. Further study of effective mitigation strategies for HA-respiratory viral infections should be prioritized; this priority is further supported by the impact of the COVID-19 pandemic on seasonal viral infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsCross InfectionRespiratory Tract InfectionsInfant, NewbornChildHumansUnited StatesInfantAdolescentRetrospective StudiesPandemicsHospitalizationDelivery of Health CareHospitals

Stichwörter der Autor:innen

escalation of respiratory supporthealthcare-associated RSVsurveillance definitionstransmission index

Autor:innen und Institutionen

  • Department of Pediatrics, NewYork-Presbyterian Morgan Stanley Children's Hospital, Columbia University Irving Medical Center, New York, New York, USA.
  • Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine at UPenn, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics, Seattle Children's Hospital, Seattle, Washington, USA.
  • Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Pediatrics, Children's Hospital at Montefiore, Bronx, New York, New York, USA.

Förderung

  • Merck Sharp & Dohme LLC
  • Merck & Co., Inc
  • Spring SHEA, Colorado Springs, CO

Zitieren

APA

Saiman, L., Coffin, S. E., Kociolek, L. K., Zerr, D. M., Milstone, A. M., Aldrich, M. L., Vargas, C. Y., Zapata, G., Zalot, M. A., Reyna, M. E., Adler, A., Voskertchian, A., Egbert, E. R., Alba, L., Gollerkeri, S., Ruggieri, M., Finelli, L., & Choi, Y. (2023). Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piad030

Vancouver

Saiman L, Coffin SE, Kociolek LK, Zerr DM, Milstone AM, Aldrich ML, et al. Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals. Journal of the Pediatric Infectious Diseases Society. 2023. doi:10.1093/jpids/piad030

BibTeX
@article{Saiman2023,
  author = {Saiman, Lisa and Coffin, Susan E and Kociolek, Larry K and Zerr, Danielle M and Milstone, Aaron M and Aldrich, Margaret L and Vargas, Celibell Y and Zapata, Giovanny and Zalot, Morgan A and Reyna, Megan E and Adler, Amanda and Voskertchian, Annie and Egbert, Emily R and Alba, Luis and Gollerkeri, Sonia and Ruggieri, Madelyn and Finelli, Lyn and Choi, Yoonyoung},
  title = {Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2023},
  doi = {10.1093/jpids/piad030}
}
Kostenlos starten →